Institutional investors hold a majority ownership of THOR through the 93.54% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended December 2013, these large investors purchased a net $1.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLB&B ADVISORS LLC Bought 11.4 Thousand shares of Thoratec Corp
STATE STREET GLOBAL ADVISORS LTD... Bought 3.6 Thousand shares of Thoratec Corp
AZZAD ASSET MANAGEMENT, INC. Bought 3.1 Thousand shares of Thoratec Corp